Mangoceuticals (MGRX) Net Cash Flow Growth (1y) (2024 - 2026)
Mangoceuticals (MGRX) Net Cash Flow Growth (1y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | -43.71% |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | 9,394.16% |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | -564.99% |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | -76.26% |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | -50.15% |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | 248.05% |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | -131.26% |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | -175.74% |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | 188.43% |
| 10 | Mangoceuticals | 5.25 Mn | 5.06 Mn | 29,001.00 | -12,932.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12,932.40% |
| Dec 31, 2025 | 14,311.36% |
| Sep 30, 2025 | 191.46% |
| Jun 30, 2025 | -94.08% |
| Mar 31, 2025 | 101.41% |
| Dec 31, 2024 | 98.58% |
| Sep 30, 2024 | 75.69% |
| Jun 30, 2024 | 144.51% |
| Mar 31, 2024 | -122.70% |